Yao-shi

The trials here

What the trial at this site is about, from its registry record.

Conditions

• COPD

Closed trials

• Completed

  Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

  NCT04751487· Phase 3· Sanofi· Source